# Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies.

> **NCT00304434** · PHASE4 · COMPLETED · sponsor: **US Department of Veterans Affairs** · enrollment: 48 (estimated)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Oseltamivir
- **DRUG:** Probenecid

## Key facts

- **NCT ID:** NCT00304434
- **Lead sponsor:** US Department of Veterans Affairs
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2009-09-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00304434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00304434, "Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies.". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00304434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*